{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T14:10:06Z","timestamp":1744899006840,"version":"3.40.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,17]]},"DOI":"10.7759\/cureus.82439","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T13:30:27Z","timestamp":1744896627000},"source":"Crossref","is-referenced-by-count":0,"title":["Chilblains With Tumid Lupus Features in a Patient With Sj\u00f6gren\u2019s Syndrome: A Case Report"],"prefix":"10.7759","author":[{"given":"Thanda","family":"Aung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mia","family":"Celestin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-012513-104728","article-title":"Sj\u00f6gren's syndrome","volume":"9","author":"Mavragani CP","year":"2014","unstructured":"Mavragani CP, Moutsopoulos HM. Sj\u00f6gren's syndrome. Annu Rev Pathol. 2014, 9:273-85. 10.1146\/annurev-pathol-012513-104728","journal-title":"Annu Rev Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3821","article-title":"Primary Sjogren syndrome","volume":"344","author":"Ramos-Casals M","year":"2012","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Sis\u00f3-Almirall A, Bosch X. Primary Sjogren syndrome. BMJ. 2012, 344:e3821. 10.1136\/bmj.e3821","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2017.0354","article-title":"The diagnosis and treatment of Sj\u00f6gren's syndrome","volume":"114","author":"Stefanski AL","year":"2017","unstructured":"Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, D\u00f6rner T. The diagnosis and treatment of Sj\u00f6gren's syndrome. Dtsch Arztebl Int. 2017, 114:354-61. 10.3238\/arztebl.2017.0354","journal-title":"Dtsch Arztebl Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2010.09033","article-title":"Dermatologic manifestations of Sj\u00f6gren syndrome","volume":"15","author":"Kittridge A","year":"2011","unstructured":"Kittridge A, Routhouska SB, Korman NJ. Dermatologic manifestations of Sj\u00f6gren syndrome. J Cutan Med Surg. 2011, 15:8-14. 10.2310\/7750.2010.09033","journal-title":"J Cutan Med Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0374-3","article-title":"Cutaneous findings in patients with primary Sjogren's syndrome","volume":"26","author":"Soy M","year":"2007","unstructured":"Soy M, Piskin S. Cutaneous findings in patients with primary Sjogren's syndrome. Clin Rheumatol. 2007, 26:1350-2. 10.1007\/s10067-006-0374-3","journal-title":"Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev200","article-title":"Characterization of systemic disease in primary Sj\u00f6gren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements","volume":"54","author":"Ramos-Casals M","year":"2015","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Seror R, et al.. Characterization of systemic disease in primary Sj\u00f6gren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology (Oxford). 2015, 54:2230-8. 10.1093\/rheumatology\/kev200","journal-title":"Rheumatology (Oxford)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2013.09.020","article-title":"Clinical characteristics, etiologic associations, laboratory findings, treatment, and proposal of diagnostic criteria of pernio (chilblains) in a series of 104 patients at Mayo Clinic, 2000 to 2011","volume":"89","author":"Cappel JA","year":"2014","unstructured":"Cappel JA, Wetter DA. Clinical characteristics, etiologic associations, laboratory findings, treatment, and proposal of diagnostic criteria of pernio (chilblains) in a series of 104 patients at Mayo Clinic, 2000 to 2011. Mayo Clin Proc. 2014, 89:207-15. 10.1016\/j.mayocp.2013.09.020","journal-title":"Mayo Clin Proc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8627-2","article-title":"The cutaneous spectrum of lupus erythematosus","volume":"53","author":"Ribero S","year":"2017","unstructured":"Ribero S, Sciascia S, Borradori L, Lipsker D. The cutaneous spectrum of lupus erythematosus. Clin Rev Allergy Immunol. 2017, 53:291-305. 10.1007\/s12016-017-8627-2","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7545","article-title":"Tumid lupus erythematosus and systemic lupus erythematosus: a report on their rare coexistence","volume":"12","author":"Jatwani K","year":"2020","unstructured":"Jatwani K, Chugh K, Osholowu OS, Jatwani S. Tumid lupus erythematosus and systemic lupus erythematosus: a report on their rare coexistence. Cureus. 2020, 12:e7545. 10.7759\/cureus.7545","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n P","year":"2016","unstructured":"Brito-Zer\u00f3n P, Baldini C, Bootsma H, et al.. Sj\u00f6gren syndrome. Nat Rev Dis Primers. 2016, 2:16047. 10.1038\/nrdp.2016.47","journal-title":"Nat Rev Dis Primers"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22859","article-title":"Association of anticentromere antibodies with more severe exocrine glandular dysfunction in Sj\u00f6gren's syndrome: Analysis of the Sj\u00f6gren's international collaborative clinical alliance cohort","volume":"68","author":"Baer AN","year":"2016","unstructured":"Baer AN, Medrano L, McAdams-DeMarco M, Gniadek TJ. Association of anticentromere antibodies with more severe exocrine glandular dysfunction in Sj\u00f6gren's syndrome: Analysis of the Sj\u00f6gren's international collaborative clinical alliance cohort. Arthritis Care Res (Hoboken). 2016, 68:1554-9. 10.1002\/acr.22859","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-0172(98)80037-1","article-title":"Cryoglobulinemia in primary Sj\u00f6gren's syndrome: prevalence and clinical characteristics in a series of 115 patients","volume":"28","author":"Ramos-Casals M","year":"1998","unstructured":"Ramos-Casals M, Cervera R, Yag\u00fce J, et al.. Cryoglobulinemia in primary Sj\u00f6gren's syndrome: prevalence and clinical characteristics in a series of 115 patients. Semin Arthr Rheum. 1998, 28:200-5. 10.1016\/s0049-0172(98)80037-1","journal-title":"Semin Arthr Rheum"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000308","article-title":"Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus","volume":"28","author":"Stannard JN","year":"2016","unstructured":"Stannard JN, Kahlenberg JM. Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus. Curr Opin Rheumatol. 2016, 28:453-9. 10.1097\/BOR.0000000000000308","journal-title":"Curr Opin Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev257","article-title":"Efficacy and safety of belimumab given for 12 months in primary Sj\u00f6gren\u2019s syndrome: the BELISS open-label phase II study","volume":"54","author":"De Vita S","year":"2015","unstructured":"De Vita S, Quartuccio L, Seror R, et al.. Efficacy and safety of belimumab given for 12 months in primary Sj\u00f6gren\u2019s syndrome: the BELISS open-label phase II study. Rheum. 2015, 54:2249-56. 10.1093\/rheumatology\/kev257","journal-title":"Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2020.03.003","article-title":"Efficacy of belimumab in primary Sj\u00f6gren's syndrome: a systematic review","volume":"17","author":"\u00c1lvarez-Rivas N","year":"2021","unstructured":"\u00c1lvarez-Rivas N, Sang-Park H, D\u00edaz Del Campo P, Fern\u00e1ndez-Castro M, Corominas H, Andreu JL, Navarro-Comp\u00e1n V. Efficacy of belimumab in primary Sj\u00f6gren's syndrome: a systematic review. Reumatol Clin (Engl Ed). 2021, 17:170-4. 10.1016\/j.reuma.2020.03.003","journal-title":"Reumatol Clin (Engl Ed)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/358811-chilblains-with-tumid-lupus-features-in-a-patient-with-sjgrens-syndrome-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T13:30:27Z","timestamp":1744896627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/358811-chilblains-with-tumid-lupus-features-in-a-patient-with-sjgrens-syndrome-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.82439","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,17]]}}}